Thursday, November 07, 2019 4:25:43 PM
I agree, and perhaps CVSciences saw this a long time ago.
Chemotype III Hemp -
"CBD-rich cultivars containing low levels of THC are regarded as fiber-type or chemotype III cultivars." (2016)
"the third one, the so-called ‘fibre’, or ‘non-drug’ type (chemotype III), has mainly CBD, an amount of THC lower than 0.3%, and therefore a high CBD/THC ratio, sometimes not calculable due to undetectability of THC (de Meijer et al. 1992). "
Fedor and Futura, the 2 cultivars CVSI uses in their self-GRAS oil, are considered Chemotype III in Europe; and I see no reason why they should not be considered the same here by the USDA/FDA; they are already on several state lists of approved seed.
It has been posted several times by a *Richard* that CVSI makes its FSHE from the non-drug fiber-hemp, while a competitor *Richard* supports uses medical-hemp. He's asked why on earth would CVSI do this, when the alternative yielded higher CBD. Not putting down the other companies, but maybe CVSI knew that creating a high quality FSHE out of a fiber-hemp cultivar will prove to be the expedient way to go. I wonder how many other FSHE companies out there use the lowly-non-cost-effective fiber-hemp cultivars.
Chemotype III Hemp -
"CBD-rich cultivars containing low levels of THC are regarded as fiber-type or chemotype III cultivars." (2016)
"the third one, the so-called ‘fibre’, or ‘non-drug’ type (chemotype III), has mainly CBD, an amount of THC lower than 0.3%, and therefore a high CBD/THC ratio, sometimes not calculable due to undetectability of THC (de Meijer et al. 1992). "
Fedor and Futura, the 2 cultivars CVSI uses in their self-GRAS oil, are considered Chemotype III in Europe; and I see no reason why they should not be considered the same here by the USDA/FDA; they are already on several state lists of approved seed.
It has been posted several times by a *Richard* that CVSI makes its FSHE from the non-drug fiber-hemp, while a competitor *Richard* supports uses medical-hemp. He's asked why on earth would CVSI do this, when the alternative yielded higher CBD. Not putting down the other companies, but maybe CVSI knew that creating a high quality FSHE out of a fiber-hemp cultivar will prove to be the expedient way to go. I wonder how many other FSHE companies out there use the lowly-non-cost-effective fiber-hemp cultivars.
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
